ENDONOVO THERAPEUTICS, INC. (ENDV)
OTC: ENDV · CIK 0001528172 · United States
Every official ENDONOVO THERAPEUTICS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ENDV filings
ENDONOVO THERAPEUTICS, INC. documents
- ENDONOVO THERAPEUTICS, INC. 10-K 2026ENDV 10-K 2026: annual report for fiscal 2026
- ENDONOVO THERAPEUTICS, INC. 10-K 2025ENDV 10-K 2025: annual report for fiscal 2025
- ENDONOVO THERAPEUTICS, INC. 10-K 2024ENDV 10-K 2024: annual report for fiscal 2024
- ENDONOVO THERAPEUTICS, INC. 10-K 2023ENDV 10-K 2023: annual report for fiscal 2023
- ENDONOVO THERAPEUTICS, INC. 10-K 2022ENDV 10-K 2022: annual report for fiscal 2022
- ENDONOVO THERAPEUTICS, INC. 10-Q 2026ENDV 10-Q 2026: quarterly report for fiscal 2026
- ENDONOVO THERAPEUTICS, INC. 10-Q 2025ENDV 10-Q 2025: quarterly report for fiscal 2025
- ENDONOVO THERAPEUTICS, INC. 10-Q 2024ENDV 10-Q 2024: quarterly report for fiscal 2024
- ENDONOVO THERAPEUTICS, INC. 10-Q 2023ENDV 10-Q 2023: quarterly report for fiscal 2023
- ENDONOVO THERAPEUTICS, INC. 10-Q 2022ENDV 10-Q 2022: quarterly report for fiscal 2022
- ENDONOVO THERAPEUTICS, INC. 8-K 2026ENDV 8-K 2026: current report for fiscal 2026
- ENDONOVO THERAPEUTICS, INC. 8-K 2025ENDV 8-K 2025: current report for fiscal 2025
- ENDONOVO THERAPEUTICS, INC. 8-K 2024ENDV 8-K 2024: current report for fiscal 2024
- ENDONOVO THERAPEUTICS, INC. 8-K 2023ENDV 8-K 2023: current report for fiscal 2023
- ENDONOVO THERAPEUTICS, INC. 8-K 2022ENDV 8-K 2022: current report for fiscal 2022
- ENDONOVO THERAPEUTICS, INC. DEF 14A 2026ENDV DEF 14A 2026: proxy statement for fiscal 2026
- ENDONOVO THERAPEUTICS, INC. DEF 14A 2025ENDV DEF 14A 2025: proxy statement for fiscal 2025
- ENDONOVO THERAPEUTICS, INC. DEF 14A 2024ENDV DEF 14A 2024: proxy statement for fiscal 2024
- ENDONOVO THERAPEUTICS, INC. DEF 14A 2023ENDV DEF 14A 2023: proxy statement for fiscal 2023
- ENDONOVO THERAPEUTICS, INC. DEF 14A 2022ENDV DEF 14A 2022: proxy statement for fiscal 2022
- ENDONOVO THERAPEUTICS, INC. Form 4 2026ENDV Form 4 2026: insider trading filing for fiscal 2026
- ENDONOVO THERAPEUTICS, INC. Form 4 2025ENDV Form 4 2025: insider trading filing for fiscal 2025
- ENDONOVO THERAPEUTICS, INC. Form 4 2024ENDV Form 4 2024: insider trading filing for fiscal 2024
- ENDONOVO THERAPEUTICS, INC. Form 4 2023ENDV Form 4 2023: insider trading filing for fiscal 2023
- ENDONOVO THERAPEUTICS, INC. Form 4 2022ENDV Form 4 2022: insider trading filing for fiscal 2022
- ENDONOVO THERAPEUTICS, INC. S-1 2026ENDV S-1 2026: registration statement for fiscal 2026
- ENDONOVO THERAPEUTICS, INC. S-1 2025ENDV S-1 2025: registration statement for fiscal 2025
- ENDONOVO THERAPEUTICS, INC. S-1 2024ENDV S-1 2024: registration statement for fiscal 2024
- ENDONOVO THERAPEUTICS, INC. S-1 2023ENDV S-1 2023: registration statement for fiscal 2023
- ENDONOVO THERAPEUTICS, INC. S-1 2022ENDV S-1 2022: registration statement for fiscal 2022
- ENDONOVO THERAPEUTICS, INC. 13F 2026ENDV 13F 2026: institutional holdings for fiscal 2026
- ENDONOVO THERAPEUTICS, INC. 13F 2025ENDV 13F 2025: institutional holdings for fiscal 2025
- ENDONOVO THERAPEUTICS, INC. 13F 2024ENDV 13F 2024: institutional holdings for fiscal 2024
- ENDONOVO THERAPEUTICS, INC. 13F 2023ENDV 13F 2023: institutional holdings for fiscal 2023
- ENDONOVO THERAPEUTICS, INC. 13F 2022ENDV 13F 2022: institutional holdings for fiscal 2022
More companies